Systematic characterization of therapeutic vulnerabilities in Multiple Myeloma with Amp1q reveals increased sensitivity to the combination of MCL1 and PI3K inhibitors https://www.biorxiv.org/content/10.1101/2023.08.01.551480v1?med=mas
Systematic characterization of therapeutic vulnerabilities in Multiple Myeloma with Amp1q reveals increased sensitivity to the combination of MCL1 and PI3K inhibitors https://www.biorxiv.org/content/10.1101/2023.08.01.551480v1?med=mas